Back
Biogen, Inc. Vs. Pfizer Inc. Industry Stock Comparison
Buy
51
BIIB
Biogen, Inc.
Last Price:
$177.78
Seasonality Move:
2.79%
Sell
46
PFE
Pfizer Inc.
Last Price:
$25.18
Seasonality Move:
0.42%
Buy
51
Biogen, Inc. (BIIB)
is a Buy
Is Biogen, Inc. a Buy, Sell or Hold?
-
The current Biogen, Inc. [BIIB] share price is $175.99. The Score for BIIB is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
BIIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Pfizer Inc. (PFE)
is a Sell
Is Pfizer Inc. a Buy, Sell or Hold?
-
The current Pfizer Inc. [PFE] share price is $25.18. The Score for PFE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
PFE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Stock Price Chart
What is Biogen, Inc.'s stock price today?
-
The Biogen, Inc. share price today is $175.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing slight selling pressure.
PFE Stock Price Chart
What is Pfizer Inc.'s stock price today?
-
The Pfizer Inc. share price today is $25.18Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PFE is experiencing slight buying pressure.
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.9 | Buy |
| Relative Strength Index (14 RSI): | 55.76 | Buy |
| Chaikin Money Flow: | -94379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (173.47 - 180.49) | Sell |
| Bollinger Bands (100): | (138.66 - 170.52) | Buy |
PFE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.75 | Buy |
| Relative Strength Index (14 RSI): | 49.13 | Sell |
| Chaikin Money Flow: | 17605604 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.01 - 25.81) | Sell |
| Bollinger Bands (100): | (24.3 - 25.74) | Buy |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 175.87 | Buy |
| 20-day SMA: | 176.03 | Sell |
| 50-day SMA: | 167.35 | Buy |
| 200-day SMA: | 141.19 | Buy |
| 8-day EMA: | 175.8 | Buy |
| 20-day EMA: | 174.77 | Buy |
| 50-day EMA: | 168 | Buy |
| 200-day EMA: | 153.82 | Buy |
PFE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.04 | Buy |
| 20-day SMA: | 25.39 | Sell |
| 50-day SMA: | 25.14 | Buy |
| 200-day SMA: | 24.48 | Buy |
| 8-day EMA: | 23.46 | Buy |
| 20-day EMA: | 16.72 | Buy |
| 50-day EMA: | 8.92 | Buy |
| 200-day EMA: | 2.61 | Buy |
Biogen, Inc. Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.69 per share.
Pfizer Inc. Earnings Growth & PFE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.11 per share.
Biogen, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pfizer Inc. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||